Valeant Pharmaceuticals

4 pages

Finance This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
BYLaura Lorenzetti
May 10, 2016
Finance Valeant Files Much Delayed Annual Earnings Saying It’s “Cured”
BYLucinda Shen
April 29, 2016
Finance Here’s Why Valeant’s Shares Are Rising
BYReuters
April 7, 2016
Finance Bill Ackman Hints Who Valeant’s Next CEO Will Be
BYJen Wieczner
April 6, 2016
Finance Here’s Why Moody’s Just Downgraded Valeant
BYJen Wieczner
April 1, 2016
Finance Bill Ackman Asked for Information in Drug Pricing Probe
BYReuters
March 25, 2016

Finance The Really Big Problem with Valeant’s Billions of Debt
BYLauren Silva Laughlin
March 23, 2016
Finance Here’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”
BYReuters
March 22, 2016
Finance Valeant Infighting Is Getting Nasty
BYJen Wieczner
March 21, 2016
Finance This Valeant Investor Is In Even Bigger Trouble than Bill Ackman
BYJen Wieczner
March 18, 2016
Finance Valeant CEO Promises Company Won’t Go Bankrupt in Staff Memo
BYJen Wieczner
March 18, 2016
Finance Even Pharma Bro Martin Shkreli Wouldn’t Touch Valeant
BYLucinda Shen
March 15, 2016
Finance Valeant’s Shares Are Having An Epically Bad Day
BYJen Wieczner
March 15, 2016
Health Valeant Just Slashed Its Profit Guidance
BYReuters and Fortune Editors
March 15, 2016
Finance Here’s What Valeant’s Earnings Tell Us About the Future of the Drug Maker
BYJen Wieczner
March 14, 2016

Most Popular

16 - 30 of 60 results